Apollomics Inc. cash flow statement

In fiscal 2025, Apollomics Inc.'s operations generated −$10.4m of cash; it spent $0 on capital projects, leaving free cash flow of −$10.4m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Apollomics Inc.: cash flow statement, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−36	−43	−43	−43	−29	−10
Stock-based pay	5	8	4	13	11	−1
Capital spending	0	0	0	0	0	0
Free cash flow	−36	−43	−43	−43	−29	−10
Free cash flow after stock pay	−40	−51	−47	−56	−40	−9

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ACRS vs APLM APLM vs COYA ADAG vs APLM

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Apollomics Inc.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Apollomics Inc.